“…The aim of the extensive narrative review by Serbis et al is to identify clinical, morphological, and immunohistochemical factors that are associated with the onset and, mainly, the recurrence of CP [11]. Molecular features such as BRAF gene mutations, altered p53 expression, increased Ki-67 expression, higher VEGF and HIF1a expression, and RARs have been extensively studied as potential predictive factors for CP relapse [11]. Moreover, the decision of whether the surgical removal is followed by radiotherapy, age, adherence to surrounding tissues, histology, specific clinical findings, and molecular features remains to be validated through well-designed multicenter prospective studies, with the ultimate goal of developing targeted adjunct therapies [11].…”